Signant Health is a United States-based company operating within the healthcare software sector, specializing in digital health technologies for clinical trials. Founded in 2000, the company has grown to employ between 1,001 and 5,000 individuals and reported significant revenue. Its expertise is reflected in its involvement with sensor-based digital health technologies, as highlighted in a recent publication discussing the implementation of these technologies in clinical trials. The article outlines key considerations for integrating digital health technologies (DHTs) into trial protocols, emphasizing the importance of participant engagement and the selection of clinically meaningful measures. Signant Health's contributions to the field include addressing challenges related to participant compliance and the effective evaluation of symptoms through digitally derived measures. The company's focus on enhancing clinical trial methodologies through innovative software solutions positions it as a notable player in the healthcare software industry, particularly in the realm of digital health and patient-centric trial designs.